Anebulo Pharmaceuticals (ANEB)

• Market cap: $25.7M
• 1 day: -10.81%
• 5 days: -29.29%
• 1 month: -34.87%
• 3 months: -67.86%
• 6 months: -47.89%
• Year to date: -59.92%
• 1 year: -52.86%
• 5 years: -86.06%
• 10 years: -86.06%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.

Employees: 2

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

0% more funds holding

Funds holding: 13 [Q2] → 13 (+0) [Q3]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q2] → 1 (+0) [Q3]

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

3.37% less ownership

Funds ownership: 31.69% [Q2] → 28.32% (-3.37%) [Q3]

37% less capital invested

Capital invested by funds: $22.4M [Q2] → $14.2M (-$8.26M) [Q3]

40% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 5

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $8 708% upside
• Avg. target: $8 708% upside
• High target: $8 708% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Benchmark Robert Wasserman 55% 1-year accuracy 27 / 49 met price target

708% upside $8

Speculative Buy Reiterated

19 Nov 2024